JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) — Long-term Investment Intensity
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has a Long-term Investment Intensity of 3.4% as of September 2019. Long-term investments of Rs674.71 Million represent 3.4% of total assets of Rs19.56 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check JBCHEPHARM asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
JB Chemicals & Pharmaceuticals Limited Long-term Investment Intensity (2014–2019)
This chart shows how JB Chemicals & Pharmaceuticals Limited's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of September 2019, the intensity stands at 3.4%, reflecting long-term investments of Rs674.71 Million against total assets of Rs19.56 Billion INR. For the complete balance sheet picture, see JB Chemicals & Pharmaceuticals Limited assets under control.
Annual Long-term Investment Intensity for JB Chemicals & Pharmaceuticals Limited (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for JB Chemicals & Pharmaceuticals Limited from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of JB Chemicals & Pharmaceuticals Limited for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (INR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 5.4% | Rs958.76 Million | Rs17.91 Billion | ▲ +2.5 pp |
| 2018 | 2.8% | Rs499.58 Million | Rs17.65 Billion | ▼ -8.3 pp |
| 2017 | 11.1% | Rs1.86 Billion | Rs16.74 Billion | ▼ -3.9 pp |
| 2016 | 15.0% | Rs2.33 Billion | Rs15.57 Billion | ▲ +2.6 pp |
| 2015 | 12.4% | Rs1.85 Billion | Rs14.87 Billion | ▲ +12.2 pp |
| 2014 | 0.2% | Rs27.48 Million | Rs13.51 Billion | — |